The role of IGF/IGF-1R signaling in hepatocellular carcinomas: stemness-related properties and drug resistance

MHT Ngo, HY Jeng, YC Kuo, JD Nanda… - International journal of …, 2021 - mdpi.com
Insulin-like Growth Factor (IGF)/IGF-1 Receptor (IGF-1R) signaling is known to regulate stem
cell pluripotency and differentiation to trigger cell proliferation, organ development, and …

Ghrelin regulating liver activity and its potential effects on liver fibrosis and Echinococcosis

J Zhu, T Zhou, M Menggen, K Aimulajiang… - Frontiers in Cellular and …, 2024 - frontiersin.org
Ghrelin widely exists in the central nervous system and peripheral organs, and has
biological activities such as maintaining energy homeostasis, regulating lipid metabolism …

Targeting IRS-1/2 in uveal melanoma inhibits in vitro cell growth, survival and migration, and in vivo tumor growth

C Chattopadhyay, R Bhattacharya, J Roszik, FS Khan… - Cancers, 2022 - mdpi.com
Simple Summary Uveal melanoma (UM) is the most common eye cancer in adults and its
spreading to the liver has poor outcomes for the patients. There is currently only one …

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic …

R Abdel-Wahab, GR Varadhachary… - Journal of hematology & …, 2018 - Springer
Background Binding of insulin-like growth factor-I (IGF-1) to its receptor (IGF-1R) initiates
downstream signals that activate PI3K/Akt/mTOR and MEK/Erk pathways, which stimulate …

[HTML][HTML] Dairy consumption and hepatocellular carcinoma risk

BC Melnik - Annals of Translational Medicine, 2021 - ncbi.nlm.nih.gov
This review provides epidemiological and translational evidence for milk and dairy intake as
critical risk factors in the pathogenesis of hepatocellular carcinoma (HCC). Large …

Promising novel biomarkers for Hepatocellular carcinoma: diagnostic and prognostic insights

J Yu, R Park, R Kim - Journal of Hepatocellular Carcinoma, 2023 - Taylor & Francis
The systemic therapy landscape for hepatocellular carcinoma is rapidly evolving, as the
recent approvals of checkpoint inhibitor-based regimens such as atezolizumab …

[HTML][HTML] The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB

MMH Al-Gayyar, A Bagalagel, AO Noor… - Biomedicine & …, 2019 - Elsevier
Insulin growth factor (IGF) family and their receptors play a great role in tumors'
development. In addition, IGF-1 enhances cancer progression through regulating cell …

Validation of a preclinical model of diethylnitrosamine-induced hepatic neoplasia in Yucatan miniature pigs

J Mitchell, PT Tinkey, R Avritscher, C Van Pelt… - Oncology, 2016 - karger.com
Objective: The purpose of this study was to reduce the time to tumor onset in a
diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC) swine model via partial …

Tumor biomarkers and interventional oncology: impact on local outcomes for liver and lung malignancy

YM Lin, R Taiji, M Calandri, BC Odisio - Current oncology reports, 2021 - Springer
Abstract Purpose of Review Interventional oncology (IO) loco-regional treatments are widely
utilized in clinical practice. However, local tumor control rates are still widely variable. There …

Serum IGF-1 scores and clinical outcomes in the phase III imbrave150 study of atezolizumab plus bevacizumab versus sorafenib in patients with unresectable …

AO Kaseb, Y Guan, B Gok Yavuz… - Journal of …, 2022 - Taylor & Francis
Purpose Child-Turcotte-Pugh class A (CTP-A) in unresectable hepatocellular carcinoma
(HCC) is the standard criterion for active therapy and clinical trial enrollment. We …